BSPM — Biostar Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2012 December 31st | C2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49.3 | 52.7 | 61.4 | 27.1 | 2.38 |
Cost of Revenue | |||||
Gross Profit | 29.9 | 25.7 | 30.3 | 11.1 | 0.915 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 71.1 | 52.2 | 62.7 | 50.9 | 5.95 |
Operating Profit | -21.8 | 0.508 | -1.31 | -23.8 | -3.56 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.6 | 2.66 | 1.53 | -23.8 | -3.05 |
Provision for Income Taxes | |||||
Net Income After Taxes | -20 | 0.809 | 4.85 | -25.1 | -5.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -20 | 0.809 | 4.85 | -25.1 | -5.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -20 | 0.809 | 4.85 | -25.1 | -5.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -10 | 0.125 | 3.16 | -10.2 | -2.48 |